Back to search
FDAFDA · Food and drugs·Recall number D-0224-2017

Duloxetine Delayed-release Capsules USP 30 mg 30-count bottles, Rx Only, Manufactured by: Inventia Healthcare Private Limited Additional Ambermath M.I.D.C., Ambermath (East) 421506, INDIA, Distributed by: Cipia USA, Inc., Miami, FL 33156, NDC 69097-298-02

Published December 28, 2016 · Recall initiated: October 19, 2016

Summary

FDA records drug Class II recall D-0224-2017, published December 28, 2016 and initiated October 19, 2016. Recalling firm: Inventia Healthcare Private Limited; Status: Terminated; Reported quantity: 46,848 delayed-release capsules; Lot: Batch # 130/16/001, 130/16/002, 130/16/003; Exp. Date 10/17 . Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications: Capsule shell (s) opening inside the bottle The Initial reports stated one or two capsules in a bottle count of 30s opening. First report came in June 14, 2016. Till date about 22 reports have come in from pharmacies which report two batches 130/16/001 and 130/16/002. Third batch 130/16/003 is not distributed yet, will be recalled from warehouse.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Inventia Healthcare Private Limited
Distributor
United States
Lot
Batch # 130/16/001, 130/16/002, 130/16/003; Exp. Date 10/17 
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Duloxetine Delayed-release Capsules USP 30 mg 30-count bottles, Rx Only, Manufactured by: Inventia Healthcare Private Limited Additional Ambermath M.I.D.C., Ambermath (East) 421506, INDIA, Distributed by: Cipia USA, Inc., Miami, FL 33156, NDC 69097-298-02 recalled?

Yes. FDA published recall D-0224-2017 on December 28, 2016. Reported hazard: Failed Tablet/Capsule Specifications: Capsule shell (s) opening inside the bottle The Initial reports stated one or two capsules in a bottle count of 30s opening. First report came in June 14, 2016. Till date about 22 reports have come in from pharmacies which report two batches 130/16/001 and 130/16/002. Third batch 130/16/003 is not distributed yet, will be recalled from warehouse.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone